Manu Tandan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Manu Tandan has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Duvvuru Nageshwar Reddy
Department of Gastroenterology, AIG Hospitals, Hyderabad, India
5 shared publications - Partha Pal
Medical Gastroenterology, Asian Institute of Gastroenterology, Hyderabad, India
4 shared publications Nitin Jagtap
Medical Gastroenterology, Asian Institute of Gastroenterology, Hyderabad, India
2 shared publications- Rajesh Gupta
Medical Gastroenterology, Asian Institute of Gastroenterology, Hyderabad, India
2 shared publications - Rupa Banerjee
IBD Center, Asian Institute of Gastroenterology, Hyderabad, India
2 shared publications - Zaheer Nabi
Asian Institute of Gastroenterology
2 shared publications
Latest Publications
- Open Access
- 1 July 2025
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 12 (7) , e01769
Transperineal Ultrasound-Guided Endoscopic Sinusotomy for Recurrent Perianal Sinus in Crohn Disease
- 1 July 2025
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 12 (7) , e01769
Open AccessTransperineal Ultrasound-Guided Endoscopic Sinusotomy for Recurrent Perianal Sinus in Crohn Disease
- Open Access
- 1 February 2025
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 12 (2) , e01609
Cholangioscopic Lithotripsy by Using Self-Expanding Metal Stent for Intrahepatic Stones in Portal Cavernoma Cholangiopathy After Failed Biliary Bypass
- 1 February 2025
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 12 (2) , e01609
Open AccessCholangioscopic Lithotripsy by Using Self-Expanding Metal Stent for Intrahepatic Stones in Portal Cavernoma Cholangiopathy After Failed Biliary Bypass
- 15 August 2024
- Published by Springer Nature in Indian Journal of Gastroenterology
- Vol. 44 (6) , 814-823
Endoscopic interventions in pancreatic strictures and stones—A structured approach
Chronic pancreatitis (CP) is an irreversible disease of varied etiology characterized by destruction of pancreatic tissue and loss of both exocrine and endocrine function. Pain is the dominant and most common presenting symptom. The common cause for pain in CP is ductal hypertension due to obstruction of the flow of pancreatic juice in the main pancreatic duct either due to stones or stricture or a combination of both. With advances in technology and techniques, endoscopic retrograde cholangiography (ERCP) and stenting should be the first line of therapy for strictures of the main pancreatic duct (MPD). Small calculi in the MPD can be extracted by ERCP and balloon trawl. Extracorporeal shockwave lithotripsy (ESWL) remains the standard of care for large pancreatic calculi and aims to fragment the stones 3 mm or less that can easily be extracted by a subsequent ERCP. Single operator pancreatoscopy with intraductal lithotripsy is a technique in evolution and can be tried when ESWL is not available or is unsuccessful in producing stone fragmentation.
- 15 August 2024
- Published by Springer Nature in Indian Journal of Gastroenterology
- Vol. 44 (6) , 814-823
Endoscopic interventions in pancreatic strictures and stones—A structured approach
Chronic pancreatitis (CP) is an irreversible disease of varied etiology characterized by destruction of pancreatic tissue and loss of both exocrine and endocrine function. Pain is the dominant and most common presenting symptom. The common cause for pain in CP is ductal hypertension due to obstruction of the flow of pancreatic juice in the main pancreatic duct either due to stones or stricture or a combination of both. With advances in technology and techniques, endoscopic retrograde cholangiography (ERCP) and stenting should be the first line of therapy for strictures of the main pancreatic duct (MPD). Small calculi in the MPD can be extracted by ERCP and balloon trawl. Extracorporeal shockwave lithotripsy (ESWL) remains the standard of care for large pancreatic calculi and aims to fragment the stones 3 mm or less that can easily be extracted by a subsequent ERCP. Single operator pancreatoscopy with intraductal lithotripsy is a technique in evolution and can be tried when ESWL is not available or is unsuccessful in producing stone fragmentation.
- 23 May 2023
- Published by Elsevier in Gastrointestinal Endoscopy Clinics of North America
- Vol. 33 (4) , 807-820
Management of Pancreatic Duct Stones: Extracorporeal Approach
- 23 May 2023
- Published by Elsevier in Gastrointestinal Endoscopy Clinics of North America
- Vol. 33 (4) , 807-820
Management of Pancreatic Duct Stones: Extracorporeal Approach
- Open Access
- 13 February 2023
- Published by MDPI AG in Gastroenterology Insights
- Vol. 14 (1) , 45-63
Systematic Review of Endoscopic Management of Stricture, Fistula and Abscess in Inflammatory Bowel Disease
Background: Interventional inflammatory bowel disease (IIBD) therapies can play a key role in inflammatory bowel disease (IBD) related stricture/fistula/abscess deferring or avoiding invasive surgery. Methods: A total of 112 studies pertaining to IIBD therapy for strictures/fistula/abscess between 2002 and December 2022 were included by searching Pubmed, Medline and Embase with a focus on technical/clinical success, recurrence, re-intervention and complications. Results: IIBD therapy for strictures include endoscopic balloon dilation (EBD), endoscopic stricturotomy (ES) and self-expanding metal stent (SEMS) placement. EBD is the primary therapy for short strictures while ES and SEMS can be used for refractory strictures. ES has higher long-term efficacy than EBD. SEMS is inferior to EBD although it can be useful in long, refractory strictures. Fistula therapy includes endoscopic incision and drainage (perianal fistula)/endoscopic seton (simple, low fistula) and endoscopic ultrasound-guided drainage (pelvic abscess). Fistulotomy can be done for short, superficial, single tract, bowel-bowel fistula. Endoscopic injection of filling agents (fistula plug/glue/stem cell) is feasible although durability is unknown. Endoscopic closure therapies like over-the-scope clips (OTSC), suturing and SEMS should be avoided for de-novo/bowel to hollow organ fistulas. Conclusion: IIBD therapies have the potential to act as a bridge between medical and surgical therapy for properly selected IBD-related stricture/fistula/abscess although future controlled studies are warranted.
- 13 February 2023
- Published by MDPI AG in Gastroenterology Insights
- Vol. 14 (1) , 45-63
Open AccessSystematic Review of Endoscopic Management of Stricture, Fistula and Abscess in Inflammatory Bowel Disease
Background: Interventional inflammatory bowel disease (IIBD) therapies can play a key role in inflammatory bowel disease (IBD) related stricture/fistula/abscess deferring or avoiding invasive surgery. Methods: A total of 112 studies pertaining to IIBD therapy for strictures/fistula/abscess between 2002 and December 2022 were included by searching Pubmed, Medline and Embase with a focus on technical/clinical success, recurrence, re-intervention and complications. Results: IIBD therapy for strictures include endoscopic balloon dilation (EBD), endoscopic stricturotomy (ES) and self-expanding metal stent (SEMS) placement. EBD is the primary therapy for short strictures while ES and SEMS can be used for refractory strictures. ES has higher long-term efficacy than EBD. SEMS is inferior to EBD although it can be useful in long, refractory strictures. Fistula therapy includes endoscopic incision and drainage (perianal fistula)/endoscopic seton (simple, low fistula) and endoscopic ultrasound-guided drainage (pelvic abscess). Fistulotomy can be done for short, superficial, single tract, bowel-bowel fistula. Endoscopic injection of filling agents (fistula plug/glue/stem cell) is feasible although durability is unknown. Endoscopic closure therapies like over-the-scope clips (OTSC), suturing and SEMS should be avoided for de-novo/bowel to hollow organ fistulas. Conclusion: IIBD therapies have the potential to act as a bridge between medical and surgical therapy for properly selected IBD-related stricture/fistula/abscess although future controlled studies are warranted.
- Open Access
- 1 March 2020
- Published by Georg Thieme Verlag KG in Journal of Digestive Endoscopy
- Vol. 11 (01) , 59-60
Be Aware, Be Alert, Be Prepared: Endoscopy during the COVID-2019 Pandemic
These are unexpected and uncertain times. The world is at war with an unseen enemy that respects no borders or ethnicity. As medical personnel doctors and health care workers (HCW) are at the forefront of this battle, we need to be well prepared. Gastroenterologists and more specifically endoscopists will come across a daily quota of patients with emergencies such as gastrointestinal (GI) bleed, obstructive jaundice, and cholangitis. Emergency endoscopy in such patients is often life saving. In this issue, Dr. P. Zachariah has clearly explained the way to go ahead with GI endoscopy during this pandemic.[1] Our own societies (Indian Society of Gastroenterology, Society of Gastrointestinal Endoscopy of India, and Indian National Association for Study of the Liver) have also put forward guidelines for proper conduct of the procedures.[2] Many other societies, especially from countries which are effected by the virus, have also advocated similar procedural guidelines and it would be worthwhile for all endoscopists to familiarize ourselves with the same.[3] [4] [5] A critical review of this article based on evidence is not feasible as no unit or center has sufficient experience of the same. It is up to each endoscopy unit to adopt to these guidelines and suggestions as well as those described in detail in the article by Dr. P. Zachariah. From our own experience as a tertiary large volume referral center with a high turnover of therapeutic endoscopic procedures, we would like to share our approach to endoscopy during the COVID-19 pandemic. We propose a timeline for endoscopic procedures to return to normalcy during and after pandemic ([Fig. 1]). Proper selection of the patient prior to the procedure is essential. As the total number of patients have reduced, a resident can be assigned for the preprocedural checkup with emphasis on COVID 19-related symptoms and contact and travel history. All elective procedures should be deferred.[6] Emergencies should be triaged.[2] [3] Low-risk patients are those who have no symptoms of flu, no travel history, or a contact with a COVID-19 positive patient. Intermediate risk is considered if a patient has one or more of the above. A high-risk patient is one who has been tested COVID-19 positive. The levels of personal protection for the endoscopists and support staff ideally should be complete in all cases.[7] However, practical issue of availability and costs are often a limitation. A high or an intermediate risk patient, however, must be endoscoped with complete protection as outlined in the article. In case these personal protection kits are in limited supply, low-risk patients can be endoscoped using a gown, cap, mask, and a self-made plastic face cover and goggles. It is ideal to delegate a single endoscopist for the entire day so that the limited resources can be utilized better. As the number of patients is bound to be limited the procedural load is unlikely to be daunting for a single endoscopist. Dr. P. Zachariah has detailed the care that should be taken during the procedure as well as shown a flow chart for the management of the endoscopy unit. High-risk HCWs should avoid performing these procedures, especially those with age >65 years, diabetes mellitus, and preexisting cardiopulmonary diseases. It is advisable to use conscious sedation in all patients because of minimizing restlessness, gagging, and coughing—all of which can contribute to aerosol spread.[6] The number of endoscopy and anesthetists assistants present in the endoscopy room should be minimized.[8] Postprocedure cleaning of the scope, endoscopy table, and surroundings have been detailed well in the article. In view of the precautions and the extra care as well as personal protection required during endoscopy procedures, it is advisable that outpatient clinics with a single endoscopist should not perform procedures during this pandemic. All patients are ideally taken care by large and tertiary setups with multiple endoscopists, resources, anesthetists, support staff, and facilities for hospitalization and intensive care. In spite of all the precautions mentioned in the various guidelines, limitations are bound to be present. As mentioned earlier, resources such as personal protection may not be available and the cost of using disposables could be a hindrance. Further asymptomatic patient may be placed in a low-risk group yet be a potential danger to HCWs and endoscopists. However, the pandemic is here. Emergencies requiring life-saving endoscopic procedures will always be seen. So, be alert, be aware, and be prepared for this situation and hope for the best outcome. Take care.
- 1 March 2020
- Published by Georg Thieme Verlag KG in Journal of Digestive Endoscopy
- Vol. 11 (01) , 59-60
Open AccessBe Aware, Be Alert, Be Prepared: Endoscopy during the COVID-2019 Pandemic
These are unexpected and uncertain times. The world is at war with an unseen enemy that respects no borders or ethnicity. As medical personnel doctors and health care workers (HCW) are at the forefront of this battle, we need to be well prepared. Gastroenterologists and more specifically endoscopists will come across a daily quota of patients with emergencies such as gastrointestinal (GI) bleed, obstructive jaundice, and cholangitis. Emergency endoscopy in such patients is often life saving. In this issue, Dr. P. Zachariah has clearly explained the way to go ahead with GI endoscopy during this pandemic.[1] Our own societies (Indian Society of Gastroenterology, Society of Gastrointestinal Endoscopy of India, and Indian National Association for Study of the Liver) have also put forward guidelines for proper conduct of the procedures.[2] Many other societies, especially from countries which are effected by the virus, have also advocated similar procedural guidelines and it would be worthwhile for all endoscopists to familiarize ourselves with the same.[3] [4] [5] A critical review of this article based on evidence is not feasible as no unit or center has sufficient experience of the same. It is up to each endoscopy unit to adopt to these guidelines and suggestions as well as those described in detail in the article by Dr. P. Zachariah. From our own experience as a tertiary large volume referral center with a high turnover of therapeutic endoscopic procedures, we would like to share our approach to endoscopy during the COVID-19 pandemic. We propose a timeline for endoscopic procedures to return to normalcy during and after pandemic ([Fig. 1]). Proper selection of the patient prior to the procedure is essential. As the total number of patients have reduced, a resident can be assigned for the preprocedural checkup with emphasis on COVID 19-related symptoms and contact and travel history. All elective procedures should be deferred.[6] Emergencies should be triaged.[2] [3] Low-risk patients are those who have no symptoms of flu, no travel history, or a contact with a COVID-19 positive patient. Intermediate risk is considered if a patient has one or more of the above. A high-risk patient is one who has been tested COVID-19 positive. The levels of personal protection for the endoscopists and support staff ideally should be complete in all cases.[7] However, practical issue of availability and costs are often a limitation. A high or an intermediate risk patient, however, must be endoscoped with complete protection as outlined in the article. In case these personal protection kits are in limited supply, low-risk patients can be endoscoped using a gown, cap, mask, and a self-made plastic face cover and goggles. It is ideal to delegate a single endoscopist for the entire day so that the limited resources can be utilized better. As the number of patients is bound to be limited the procedural load is unlikely to be daunting for a single endoscopist. Dr. P. Zachariah has detailed the care that should be taken during the procedure as well as shown a flow chart for the management of the endoscopy unit. High-risk HCWs should avoid performing these procedures, especially those with age >65 years, diabetes mellitus, and preexisting cardiopulmonary diseases. It is advisable to use conscious sedation in all patients because of minimizing restlessness, gagging, and coughing—all of which can contribute to aerosol spread.[6] The number of endoscopy and anesthetists assistants present in the endoscopy room should be minimized.[8] Postprocedure cleaning of the scope, endoscopy table, and surroundings have been detailed well in the article. In view of the precautions and the extra care as well as personal protection required during endoscopy procedures, it is advisable that outpatient clinics with a single endoscopist should not perform procedures during this pandemic. All patients are ideally taken care by large and tertiary setups with multiple endoscopists, resources, anesthetists, support staff, and facilities for hospitalization and intensive care. In spite of all the precautions mentioned in the various guidelines, limitations are bound to be present. As mentioned earlier, resources such as personal protection may not be available and the cost of using disposables could be a hindrance. Further asymptomatic patient may be placed in a low-risk group yet be a potential danger to HCWs and endoscopists. However, the pandemic is here. Emergencies requiring life-saving endoscopic procedures will always be seen. So, be alert, be aware, and be prepared for this situation and hope for the best outcome. Take care.
- 1 October 2019
- Published by Elsevier in Pancreatology
- Vol. 19 (7) , 916-921
ESWL for large pancreatic calculi: Report of over 5000 patients
- 1 October 2019
- Published by Elsevier in Pancreatology
- Vol. 19 (7) , 916-921
ESWL for large pancreatic calculi: Report of over 5000 patients
- Open Access
- 1 April 2019
- Published by Georg Thieme Verlag KG in Journal of Digestive Endoscopy
- Vol. 10 (02) , 075-076
ESWL—The Shocks are Beneficial
- 1 April 2019
- Published by Georg Thieme Verlag KG in Journal of Digestive Endoscopy
- Vol. 10 (02) , 075-076
Open AccessESWL—The Shocks are Beneficial
- Open Access
- 15 November 2016
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 10 (6) , 873-880
Management of Pancreatic Calculi: An Update
Manu Tandan, Rupjyoti Talukdar, and Duvvur Nageshwar Reddy. Gut and Liver 2016;10:873-80. https://doi.org/10.5009/gnl15555
- 15 November 2016
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 10 (6) , 873-880
Open AccessManagement of Pancreatic Calculi: An Update
Manu Tandan, Rupjyoti Talukdar, and Duvvur Nageshwar Reddy. Gut and Liver 2016;10:873-80. https://doi.org/10.5009/gnl15555
- Open Access
- 13 October 2016
- Published by Springer Nature in BMC Gastroenterology
- Vol. 16 (1) , 1-9
Addition of Lubiprostone to polyethylene glycol(PEG) enhances the quality & efficacy of colonoscopy preparation: a randomized, double-blind, placebo controlled trial
Adequate bowel preparation is an essential prerequisite for complete mucosal visualization during colonoscopy. Polyethylene glycol (PEG) solutions are commonly used. However the large volume of the solution is often poorly tolerated. Addition of Lubiprostone (LB) could improve the adequacy of standard PEG preparation & reduce requirement. The aims to assess adequacy of PEG preparation with addition of single dose LB (24mcg) vs placebo and efficacy of reduced dose PEG + LB compared with full dose PEG + LB. Single center prospective double blind randomized controlled trial. Part I: 442 patients for colonoscopy randomized to receive placebo (GrA) or single dose of LB (GrB) prior to PEG preparation. Quality of bowel preparation graded 0–9 according to Boston Bowel Preparation Scale (BBPS). BBPS-9: excellent and BBPS 0–4: repeat procedure. Part II: 146 patients randomized to receive LB + 1.5 L PEG (GrC; 75) or LB + 1 L PEG (GrD; 71). BBPS score compared with GrB (2 L PEG). Part I: 442 patients (221 GrA & 221 Gr B). LB resulted in significant improvement in total BBPS (7.44 + 0.14 vs. 6.36 + 0.16, p < 0.0001). 66.5 % Gr B vs 38 % Gr A had excellent prep; 42.5 % GrB vs 24 % GrA had adequate prep. Repeat procedure needed 9.5 % Gr B vs 16.7 % Gr A (P < 0.01). Part II: No difference in BBPS scores with lower doses (Gr C&D) compared to standard (GrB) (Mean BBPS 7.44 + 0.14 GrA,7.30 + 0.25 GrC;7.25 + 0.26 GrD;p >0.05). Single dose LB prior to PEG significantly enhanced bowel preparation compared to PEG alone. There was no significant difference in quality of preparation with lower doses of PEG when combined with LB. The study protocol was approved by institutional review board and the trial was registered on March 22, 2011 with clinicaltrials.gov ( NCT01324284 ).
- 13 October 2016
- Published by Springer Nature in BMC Gastroenterology
- Vol. 16 (1) , 1-9
Open AccessAddition of Lubiprostone to polyethylene glycol(PEG) enhances the quality & efficacy of colonoscopy preparation: a randomized, double-blind, placebo controlled trial
Adequate bowel preparation is an essential prerequisite for complete mucosal visualization during colonoscopy. Polyethylene glycol (PEG) solutions are commonly used. However the large volume of the solution is often poorly tolerated. Addition of Lubiprostone (LB) could improve the adequacy of standard PEG preparation & reduce requirement. The aims to assess adequacy of PEG preparation with addition of single dose LB (24mcg) vs placebo and efficacy of reduced dose PEG + LB compared with full dose PEG + LB. Single center prospective double blind randomized controlled trial. Part I: 442 patients for colonoscopy randomized to receive placebo (GrA) or single dose of LB (GrB) prior to PEG preparation. Quality of bowel preparation graded 0–9 according to Boston Bowel Preparation Scale (BBPS). BBPS-9: excellent and BBPS 0–4: repeat procedure. Part II: 146 patients randomized to receive LB + 1.5 L PEG (GrC; 75) or LB + 1 L PEG (GrD; 71). BBPS score compared with GrB (2 L PEG). Part I: 442 patients (221 GrA & 221 Gr B). LB resulted in significant improvement in total BBPS (7.44 + 0.14 vs. 6.36 + 0.16, p < 0.0001). 66.5 % Gr B vs 38 % Gr A had excellent prep; 42.5 % GrB vs 24 % GrA had adequate prep. Repeat procedure needed 9.5 % Gr B vs 16.7 % Gr A (P < 0.01). Part II: No difference in BBPS scores with lower doses (Gr C&D) compared to standard (GrB) (Mean BBPS 7.44 + 0.14 GrA,7.30 + 0.25 GrC;7.25 + 0.26 GrD;p >0.05). Single dose LB prior to PEG significantly enhanced bowel preparation compared to PEG alone. There was no significant difference in quality of preparation with lower doses of PEG when combined with LB. The study protocol was approved by institutional review board and the trial was registered on March 22, 2011 with clinicaltrials.gov ( NCT01324284 ).